comparemela.com

Latest Breaking News On - Nasdaq path - Page 1 : comparemela.com

UiPath Inc (NASDAQ:PATH) Given Consensus Recommendation of Hold by Brokerages

UiPath Inc. (NASDAQ:PATH – Get Rating) has been given an average rating of “Hold” by the twenty-two analysts that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company. The average 12-month […]

Recent Analysts Ratings Changes for UiPath (PATH)

Several analysts have recently updated their ratings and price targets for UiPath (NASDAQ: PATH): 6/2/2022 – UiPath had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $23.00. They now have a “buy” rating on the stock. 6/2/2022 – UiPath had its price target lowered by analysts at BMO Capital Markets […]

Evercore ISI Lowers UiPath (NASDAQ:PATH) Price Target to $23 00

UiPath (NASDAQ:PATH – Get Rating) had its price target reduced by research analysts at Evercore ISI from $28.00 to $23.00 in a research note issued to investors on Thursday, The Fly reports. Evercore ISI’s price objective indicates a potential upside of 36.66% from the stock’s current price. PATH has been the topic of several other […]

UiPath (NASDAQ:PATH) PT Lowered to $45 00 at Credit Suisse Group

UiPath (NASDAQ:PATH – Get Rating) had its price target cut by Credit Suisse Group from $57.50 to $45.00 in a research report issued to clients and investors on Thursday, The Fly reports. Credit Suisse Group’s target price indicates a potential upside of 167.38% from the stock’s current price. Several other research firms have also recently […]

UiPath (NASDAQ:PATH) Price Target Lowered to $45 00 at Truist Financial

UiPath (NASDAQ:PATH – Get Rating) had its price objective cut by equities research analysts at Truist Financial from $55.00 to $45.00 in a research report issued to clients and investors on Thursday, The Fly reports. Truist Financial’s target price would suggest a potential upside of 143.51% from the stock’s current price. Several other equities research […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.